Daily - Go to TTD's     Chart scroller of  Breakout Stocks    - Friday-  March 19, 2021

{short description of image}

Daily - Bullish Investors  - Go To TTD Pre-Market Opening Breakout Watch  List  - Friday - March 19, 2021

Daily - Bullish Aggressive Investor - Go To TTD Quick Trade Setups (74% win rate) - Friday - March 19, 2021

Go To Prior Days TTD "Reports"

Go to Video Show - "How to Make Money With Breakout Stocks

{short description of image}

Ticker Tape Digest

Friday - March 19, 2021

By Leo Fasciocco -- TTD

   Ticker Tape Digest presents its daily stock market report containing stocks to go long as Breakout Trades, Quick Trades, or Bargain Accumulation Trades.

  We also feature stocks under Significant Accumulation that are poised to breakout.

Ticker Tape Digest's

Daily schedule guide for TTD subscribers

1. Pre-market - check Breakout Watch List and Quick Trades.

2. Morning - (11:30 - 12 A.M.) - check breakout stocks tape and breakout chart slide show.

3. Midday (1 P.M.) check TTD Midsession Report and see market video show.

4. After close (4 P.M.) check final TTD Report for day.

Trading Strategies


Aggressive Investors Bullish - "Breakout Stocks" - ideally suited for bull markets and special situation stocks. Potential for large returns. (See Performance)

Aggressive Investor Bullish-  "Quick Trade Stocks" -ideally suited for entry into top performing issues looking for a small quick profit."  (See Performance)

Conservative Investors  "Bargain Buy Trades for the Long Term."  Ideally suited for entry into top performing big cap stocks on pullbacks within overall up trend.(See Performance)


Aggressive Bearish Investors - "Breakdown Stocks" to Sell Short. Ideally suited for bear markets or market pull backs. Potential for large returns  (See Performance)

   The TTD report also contains stocks to short as  breakdown plays and as bargain (swing trade) shorts.

  Investors should  tend to try to go with a strategy that fits with the stock market's trend, unless there is a special situation play.

  TTD's Breakout Stocks - Long are most suitable for aggressive investors seeking ideal entry points into leading stocks, especially during bull markets. They can do extremely well in bull markets with gains of as much as several hundred percent.

 These stocks can also do extremely well during strong market rallies, or if they are in a industry group that is performing very well. They tend to have strong earnings outlooks and are near new-52 week, or all-time highs.

  TTD Quick Trade Stocks - Long These are leading issues that have pulled back in recent days, but could move higher soon. They are most suitable for Aggressive Investors willing to trade short term. These stocks will do extremely well during market advances. They have about 74% win rate. During market rally sequences the win rate is even higher. The return is small 3% to 8% in just a few days.

   TTD also presents Stocks To Sell or Sell Short. These issues are suitable for aggressive investors willing to take short positions both as trades or for longer-term plays. These stocks will do very well during bear markets or market pull backs.

  TTD's Bearish breakdown stocks to sell short. These issues have potential to fall sharply. They often show a technical breakdown and also some fundamental business problem such as weak earnings.  

 TTD's multi-media updates include a slide-show that presents charts and analysis at midsession. Some times TTD presents feature analysis on stocks and the market. TTD uses Windows Media Files. (WMV).

 TTD also presents a "Breakout Watch List" that is up dated daily. This list consists of key stocks in position to breakout. A close watch of this list can put you in the stock just as it breaks out. A good idea is to study the list and be ready to move into a stock quickly as it hits its breakpoint.

TTD often suggests using stop buy orders to enter. It is very important to buy a breakout stock as close as possible to the breakpoint. The idea is to get "elbow room" if the stock should follow through to the upside. This is very important in being successful in making big money with breakout stocks.

It is also essential to have a stop loss strategy for all stocks in which positions are taken. Not every stock will work as expected. It is important for investors to "police" their portfolios and avoid getting trapped in any bad positions.

 Quality rating of breakout  Two key factors: 1 - Stock near all-time high in price or near a 52-week high. 2 - earnings growth current year is strong. The ideal play is a stock with an Above Average Quality Rating. The stock is near a new high and will have strong earnings. TTD's other ratings are Average and Below Average.

Quote or chart

   TTD also has  special feature sections on  Educational Tips on Investing.

   To email Mr. Leo Fasciocco  leo@tickertapedigest.com.   

   For service, email Beverly Owen owen@tickertapedigest.com. TTD’s Tel: 1-480-878-8381 or 480-704-3331.

Friday - March 19, 2021

TTD's Breakout Stocks

  Stock Market Overview

Total Buy Breakouts   -  3

Quality of Breakouts -  Average.

Stocks Screened - 12,234

Bull side -  Small list of breakouts

Stock market  -  Major averages are bullish in all time zones, except fro the daily Nasdaq which is bearish.

Comment -  Stock market holding its up trend, except for the Nasdaq. Market is a bit volatile. Bulls must be careful.

See Latest Earnings Reports -  A company that tops the Street's highest earnings estimate has potential to go higher. Key earnings beats -  WTT.

Stock Market Momentum

(Daily is based on a moving average)

Market (Daily)

 Market (Weekly)

 Market (Monthly)  

 Dow - Bullish

 Dow - Bullish

 Dow - Bullish

  Nasdaq - Bearish

  Nasdaq - Bullish

Nasdaq - Bullish

   S&P 500 - Bullish

  S&P 500 - Bullish

  S&P 500 - Bullish

Ticker Tape Digest's

Timely Breakout Stocks From Tape Action

(The “breakout List” gives all stocks breaking out of a base of five weeks or more. These stocks have a good chance to trend higher. However, a stop should be used to avoid those that do not work.

They are ranked according to percentage change and classified as leaders or other.

(Trading strategy: One should buy breakout stocks near breakpoint by using market order or stop buy.  They can also be bought soon after a follow through move, sometimes on an intraday pullback. )  

Today's Featured TTD Breakout Stock

Ortho Clinical Diagnostics (OCDX) - 18.63, up 1.71 - Breakpoint 18.50

Net To Climb This Year, TTD Targets 23

      TTD's Quality Rating of Stock - OCDX  - ABOVE AVERAGE

  OCDX, based in Raritan, N.J., makes medical diagnostics products. Annual revenues: $1.8 billion. OCDX's stock drives higher Friday and breaks out from its six-week, flat base.

  So far today, OCDX is trading a heavy 16.8 million shares. 12 times its average daily volume.

 TTD sees potential for more on the upside.

  The stock is best suited for an aggressive bulls.

  OCDX's stock gapped higher in the morning. It then trended sideways.

  Around noon, it cleared its breakpoint line.

  In after-hours trading, the stock was off 23 cents a share.

 The company is involved in Covid-19 testing.

   Tape Action

  OCDX's tape action shows the recent block trades.

  One can see the price for the blocks surging from $16.92 to as high as $18.63.

  A key bullish trade came at the opening when a block of 42,845 shares crossed the tape at $18.03.

  That was up from the prior block the day before at $16.92 on 91,428 sharers.

  Near the close a big block of 1,036.693 shares (duplicated) crossed the tape at $18.63.

  That was up from the prior block at $18.62 on 38,000 shares.


  OCDX is an in-vitro diagnostics company.

The company provides laboratory testing and blood-typing solutions to the clinical laboratory and transfusion medicine communities.

 CCDX provides customized solutions for clinical outcomes, lab performance and staffing challenges.

The company operates through two lines of business such as Clinical Labs and transfusion medicine.

Its donor screening business focuses on instruments and tests used for blood and plasma screening for infectious diseases.


  OCDX's stock came public in January.

  Its 2-month performance chart shows the stock up 15% versus a 7% gain for the stock market.

  OCDX has not reported any insider activity.

  OCDX's long-term  chart - just a few months - shows the stock up 15% versus a 7% gain for the stock market over that period.

  OCDX's daily chart shows the stock climbing from $15.50 in January to a peak near $18.50 in February.

  The stock then pulled back and formed a flat base.

  Friday, OCDX spikes higher with big volume and clears its base.

  The stock's CCI momentum indicator is strongly bullish.

   Earnings Outlook

  This year, OCDX's earnings are projected to leap 68% to 57 cents a share from the 34 cents the prior year.

  The stock has a price-earnings ratio of 32.

  Looking out to 2022, the Street expects a 24% rise in net to 71 cents a share from the anticipated 57 cents this year.

  Net for the first quarter should come in at 11 cents a share. Then in the second quarter net is expected to be 11 cents a share again.

Strategy Opinion:  TTD is targeting OCDX for a move to $23 within the next few months, or sooner.

A protective stop can be placed near $17.20

Intermediate-Term Rating: Average.

Suitability:   Aggressive Bulls.

                                 TTD's special research of Stock's Prior Performance:  

Breakout Success


  OCDX scored big gains off recent breakouts.

Response to Net


  OCDX  rose 1 time after 1 earnings reports.

Seasonal Success


  OCDX avg. gain 7.7% in March.

Earnings Beats


  OCDX beat Street net estimate 0 times after 1 report.

           Stock's Prior Performance After A Breakout

Stock's % Change from Breakout to peak - prior  to cut below 50-day M/A.

Date of Breakout

Break point Price

Stocks Price Peak after Breakout - prior to cut below 50-day M/A

  Date Trade Closed


   3/19/2021      18.55        18.63    Still in play

(In actual trading, entry and exit points could vary depending on broker execution.

Also, ideal are breakouts to a new 52-week high or better, perhaps all-time highs.)

  Stock's Long-term Chart

   Stock's Price Performance after Reporting Earnings


 Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500

Insider Buying in Green  -  Insider Selling in Red

Charts of Selected Breakout Stocks

      TTD's Quality Rating of Stock - TME - AVERAGE

      TTD's Quality Rating of Stock - REKR -  BELOW  AVERAGE


Ticker Tape Digest’s

Stocks To “Sell or Short”

    Ticker Tape Digest’s Daily List of “Stocks To Sell or Sell Short” ranks stocks well timed to be sold immediately based on daily trading. The list can be used as an alert to reduce current long-term positions.

Shorts from tape action  - 3

Stocks Screened - 12,234

Long-Term Environment for bears: Unfavorable.

Bear Side -  Small list of short plays but some interesting plays.

List of Stocks To Sell or Short

TTD’s Feature Bear Play

Idera Pharmaceuticals Inc. (IDRA) - 1.98

Loss Seen This Year and Next, TTD Sees Drop to 1.20

  IDRA, based in Exton, Pa.,is a biotech firm  producing drugs for oncology and certain diseases. Annual revenues: 1.5 million. IDRA's stock gaps sharply lower Friday and undercuts key technical support.

  So far today, IDRA is trading a heavy 50 million shares, 35 times its average daily volume of 1.4 million shares.

  The big drop came when IDRA's drug failed its test.

   TTD sees potential for more on the downside even though IDRA is now low priced.

   IDRA's stock gapped lower in the morning and cut below key technical support.

   The stock touched a low of $1.81 in the morning.

   The stock lifted slightly and then trended sideways the rest of the day.

   Tape Action

  IDRA's tape action shows the recent block trades.

  One can see the price for the blocks falling from $2 a share to as low as $1.88.

  A key bearish trade came in the morning when a block of 46,000 shares crossed at $1.97 a share.

  That was down from the prior block at $2 on 46,900 shares.


  IDRA works on drugs  to treat oncology and rare diseases.

 The company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor  targeting technology and third-generation antisense technology.


 This year, analysts forecast a loss of 54 cents a share compared with a loss of $1.08 the prior year.

  For the first quarter, analysts expect a loss of 8 cents a share compared with a loss of 43 cents the prior year.


  IDRA's hit a peak at $5.71 in January. The stock then trended lower to $3.72 in March. The stock did lift, but Friday IDRA gapped lower with big volume.

Strategy Opinion: TTD  is targeting IDRA for a decline to $1.20 within the next few months, or sooner. A protective stop buy can be placed near $2.30

Suitability:  Aggressive Bears.

  TTD's Stock Probability research of Prior Performance:  

Response to Net


 IDRA rose 6 times after 13 earnings reports.

Seasonal Success


 IDRA loss avg 8.8% in March, rose 11% in April prior years.

Earnings Beats


 IDRA beat Street estimate 7 times after 9 reports.

   TTD's Quality Rating of Stock  - IDRA -  BELOW AVERAGE

   Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500

Insider Buying in Green  - Insider Selling in Red


   TTD takes no responsibility for trading by those using this information. The stocks presented in our report are those we deem the best looking "Day Trades" for the long side. We take no responsibility for the accuracy of this data, although every effort is made to present the information correctly. Copyright Ticker Tape Digest. - 2021

    TTD columnist Leo Fasciocco has covered the stock market for over 30 years. His articles appear in many publications. He has also been  a speaker at the Money Show conferences. He has been on television and radio. He is author of many educational articles about stock investing and the book “Guide To High-Performance Investing.”

{short description of image}

   For information to subscribe to the Ticker Tape Digest Services call: Beverly Owen at 1-480-704-3331.

   Distributed by Corona Publishing Enterprises. TickerTape Digest Inc. 1220 W. Sherri, Gilbert, Az. 85233.

  TTD “Professional Report” is available on the Web: $100 per month. Password needed. Published daily - around 20 times a month.  

 TTD Pro Report includes a Morning chart slide show of breakout stocks, a Midsession video-audio show with commentary on breakout stocks and shorts and a Final end of day overall report on breakout stocks for the session, short plays and accumulation plays.  There are other features too such as Quick Trades and Long-term Plays.  

TTD Daily Report is $39. It covers a Morning slide show of charts of stocks breaking out and a TTD end of day print report covering breakout stocks and shorts.

 Credit cards accepted. Payable to Corona Publishing Enterprises.

(The information contained has been prepared from data deemed reliable but there is no guarantee of complete accuracy. Ticker Tape Digest Inc. is not affiliated with any broker, dealer or investment advisor. Nothing in this publication constitutes an offer, recommendation or solicitation to buy or sell any securities. Further research is advised. This report is copyrighted and no redistribution is permitted with out permission.)